Categories
| Category | |
|---|---|
| Health | 53% |
| Developmental and Physical Disabilities | 7% |
| Biotechnology and Pharmaceuticals | 7% |
| Others | 33% |
Explore sites in same category:
- myspondylitisteam.com Rank 1.4M. Estimated value 1,548$
- elisoler.com Rank 2M. Estimated value 1,056$
- pozvonochnik.info Rank 842.9K. Estimated value 2,556$
- docvita.com Rank 636.3K. Estimated value 3,396$
- arabaltmed.com Rank 1M. Estimated value 2,100$
- drbacsi.com Rank 3.2M. Estimated value 660$
- twedr.com Rank 210.3K. Estimated value 10,356$
- jlfisios.com Rank 1.2M. Estimated value 1,740$
- amansi.net Rank 3.2M. Estimated value 672$
- iadt.com Rank 0.9M. Estimated value 2,364$
Keyword Suggestion
Domain Informations
Vabysmo.com lookup results from whois.safenames.net server:
- Domain created: 2020-06-18T10:04:02Z
- Domain updated: 2024-07-01T08:03:06Z
- Domain expires: 2026-06-18T10:04:02Z 0 Years, 159 Days left
- Website age: 5 Years, 205 Days
- Registrar Domain ID: 2539566142_DOMAIN_COM-VRSN
- Registrar Url: http://www.safenames.net
- Registrar WHOIS Server: whois.safenames.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.1908200022
- Name server:
- ALAN.NS.CLOUDFLARE.COM
- LARA.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2024-11-25
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.27.181
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.27.181)
Spam Check (IP: 104.18.27.181)
Websites Listing
We found Websites Listing below when search with vabysmo.com on Search Engine
Health Canada authorizes VABYSMO® (faricimab injection) for the ...
Web Jan 6, 2022 · VABYSMO is a humanized bispecific immunoglobulin G1 (IgG1) antibody that acts through inhibition of both Ang-2 and vascular endothelial growth factor A (VEGF-A). …
Rochecanada.comVABYSMO™ (faricimab-svoa) | nAMD and DME Treatment
Web VABYSMO (faricimab-svoa) is a vascular endothelial growth factor (VEGF) inhibitor and angiopoietin-2 (Ang-2) inhibitor indicated for the treatment of patients with Neovascular …
Vabysmo-hcp.comContact Genentech | VABYSMO™ (faricimab-svoa)
Web VABYSMO should not be used during pregnancy unless the potential benefit to the patient outweighs the potential risk to the fetus. The developmental and health benefits of …
Vabysmo-hcp.comFDA Accepts Application for Genentech’s Vabysmo for …
Web May 9, 2023 · Vabysmo is contraindicated in patients who have an infection in or around their eye, have active swelling around their eye that may include pain and redness, or …
Morningstar.comGenentech: Press Releases | Monday, May 8, 2023
Web May 8, 2023 · Vabysmo may cause a temporary increase in pressure in the eye (intraocular pressure), which occurs 60 minutes after the injection. Although not common, Vabysmo …
Gene.comHealth Canada authorizes VABYSMO® (faricimab injection) for
Web Jun 1, 2022 · VABYSMO ® (faricimab injection) is the first bispecific antibody that acts by neutralizing both VEGF-A and Ang-2 proteins, a dual mode of action (MoA) 2, 3, 4, 5
Newswire.caFDA accepts application for Roche’s Vabysmo for the
Web May 9, 2023 · Vabysmo’s efficacy and safety profile in nAMD and DME is supported by four large, global studies involving more than 3,000 participants and extensive real-world …
Globenewswire.comFDA Accepts Application for Genentech’s Vabysmo for the …
Web May 9, 2023 · Vabysmo is contraindicated in patients who have an infection in or around their eye, have active swelling around their eye that may include pain and redness, or …
Businesswire.comGenentech: Vabysmo® (faricimab-svoa) - Information for Patients
Web VABYSMO may cause a temporary increase in pressure in the eye (intraocular pressure), which occurs within 60 minutes after receiving the eye injection. Although not common, …
Gene.comFDA accepts application for Roche’s Vabysmo for the treatment of ...
Web May 9, 2023 · Vabysmo’s efficacy and safety profile in nAMD and DME is supported by four large, global studies involving more than 3,000 participants and extensive real-world …
Finance.yahoo.comCADTH Reimbursement Recommendation Faricimab (Vabysmo)
Web Although Vabysmo can be given at an interval of up to every 16 weeks, there is not enough evidence to prove that treatment with Vabysmo results in fewer injections than other …
Cadth.ca2023-05-09 | OTCQX:RHHBY | Press Release - Stockhouse
Web May 9, 2023 · Vabysmo is the first bispecific antibody approved for the eye and was approved in the United States for the treatment of wet, or neovascular, age-related …
Stockhouse.comFDA Accepts SBLA For Genentech's Vabysmo For Retinal Vein
Web May 9, 2023 · Vabysmo's safety profile was consistent with previous trials. If approved, retinal vein occlusion or RVO would be the third indication for Vabysmo in addition to …
Nasdaq.comFDA accepts supplemental biologics license application for …
Web May 9, 2023 · The FDA has accepted a supplemental biologics license application from Genentech for Vabysmo for the treatment of macular edema following retinal vein …
Healio.comPodemos se asoma al abismo financiero: 200.000 euros si no entra …
Web 2 days ago · Podemos se asoma al abismo financiero: 200.000 euros si no entra en Madrid. Los morados han recaudado 1.150.000 euros en microcréditos para el 28-M, …
Elconfidencial.comEl PP intenta salir del abismo en Cataluña y centra sus ... - El País
Web May 11, 2023 · El presidente del Partido Popular, Alberto Núñez Feijóo y el alcaldable por Barcelona, Dani Sirera, el dia de Sant Jordi. / Lorena Sopena / Europa Press Lorena …
Elpais.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| sugarridgeresort.com | fabulous.com | 255 Days |
| manezo.com | gmo.jp | -3 Years, -26 Days |
| 0717jfenglish.com | godaddy.com | -3 Years, -77 Days |
| imaginaryauthors.com | godaddy.com | -1 Years, -290 Days |
| matfranco.com | tucows.com | -3 Years, -97 Days |
| lwlies.com | ionos.com | -3 Years, -317 Days |
| afpfilm.com | realtimeregister.com | -3 Years, -225 Days |
| neghl.org | whois.godaddy.com | -3 Years, -319 Days |
| picshood.com | godaddy.com | -3 Years, -163 Days |
| drgambhir.com | gomontenegrodomains.com | -3 Years, -58 Days |